Nuclear medicine. Developed with input from Rosatom, a new radiopharmaceutical based on radium-223 proved effective in treating prostate cancer. After all the trials are completed, it will replace an imported original drug. While not inferior in quality, the Rosatom-made drug is cheaper. The radiopharmaceuticals produced by Rosatom enable about 2.5 million diagnostic and therapeutic procedures to be performed in Russia and abroad. Rosatom is the world’s Top 5 supplier of isotopes for cancer diagnostics and treatment.